These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8960339)

  • 41. Pseudomyxoma peritonei.
    Bair MJ; Lin IT; Chen HL; Wu CH
    Am J Med Sci; 2010 Oct; 340(4):319. PubMed ID: 20631610
    [No Abstract]   [Full Text] [Related]  

  • 42. The influence of tumor cell entrapment phenomenon on the natural history of Pseudomyxoma peritonei syndrome.
    Spiliotis J; Efstathiou E; Halkia E; Vaxevanidou A; Datsis A; Sugarbaker P
    Hepatogastroenterology; 2012 May; 59(115):705-8. PubMed ID: 22469712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudomyxoma peritonei.
    Shukla J; Sharma V
    J R Coll Physicians Edinb; 2023 Sep; 53(3):184-185. PubMed ID: 37329264
    [No Abstract]   [Full Text] [Related]  

  • 44. Images in pathology: pseudomyxoma peritonei masquerading as abdominal hydatidosis.
    Narayana Swamy YV; Kini U; Amirtham U; Lahoti NK
    J Postgrad Med; 2000; 46(4):288-90. PubMed ID: 11435660
    [No Abstract]   [Full Text] [Related]  

  • 45. Pseudomyxoma peritonei.
    Jivan S; Bahal V
    Postgrad Med J; 2002 Mar; 78(917):170-2. PubMed ID: 11884702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pseudomyxoma peritonei presenting as inguinal hernia.
    Campbell P; Dawson S; Wali J; Kenny B; Whiteside MC
    Ulster Med J; 2009 Sep; 78(3):189-90. PubMed ID: 19907691
    [No Abstract]   [Full Text] [Related]  

  • 47. Ultrasound imaging of pseudomyxoma peritonei with numerous vesicles in ascitic fluid.
    Matsumi H; Kozuma S; Osuga Y; Yano T; Yoshikawa H; Tsutsumi O; Taketani Y
    Ultrasound Obstet Gynecol; 1999 May; 13(5):378-9. PubMed ID: 10380313
    [No Abstract]   [Full Text] [Related]  

  • 48. Ascitic fluid cytology in a rare case of pseudomyxoma peritonei originating from intraductal papillary mucinous neoplasm of the pancreas.
    Nepka Ch; Potamianos S; Karadana M; Barbanis S; Kapsoritakis A; Koukoulis G
    Cytopathology; 2009 Aug; 20(4):271-3. PubMed ID: 19207311
    [No Abstract]   [Full Text] [Related]  

  • 49. Pseudomyxoma peritonei: the 'controversial' disease.
    Galani E; Marx GM; Steer CB; Culora G; Harper PG
    Int J Gynecol Cancer; 2003; 13(4):413-8. PubMed ID: 12911716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
    Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
    World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pseudomyxoma peritonei: a rare disease and a disease model in peritoneal surface oncology.
    González-Moreno S
    Clin Transl Oncol; 2011 Apr; 13(4):211-2. PubMed ID: 21493179
    [No Abstract]   [Full Text] [Related]  

  • 52. Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms.
    Menassel B; Duclos A; Passot G; Dohan A; Payet C; Isaac S; Valette PJ; Glehen O; Rousset P
    Eur J Surg Oncol; 2016 Apr; 42(4):558-66. PubMed ID: 26856956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudomyxoma peritonei.
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Cancer Treat Rev; 2007 Apr; 33(2):138-45. PubMed ID: 17182192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pseudomyxoma retroperitonei presenting with a skin fistula.
    Cakmak A; Karakayali F; Bayar S; Unal E; Akyol C; Kocaoğlu H
    Turk J Gastroenterol; 2009 Mar; 20(1):79-80. PubMed ID: 19330745
    [No Abstract]   [Full Text] [Related]  

  • 55. Nomogram to predict overall survival of patients with pseudomyxoma peritonei of appendiceal origin: A retrospective cohort study.
    Bai M; Wang S; Ma R; Cai Y; Lu Y; Hou N; Liang G; Xu H; Zhang M
    J Surg Oncol; 2021 Dec; 124(8):1459-1467. PubMed ID: 34634135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.
    Sugarbaker PH
    Ann Surg; 1994 Feb; 219(2):109-11. PubMed ID: 8129480
    [No Abstract]   [Full Text] [Related]  

  • 57. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudomyxoma peritonei of hernial sac--a case report.
    Jaswal TS; Singh S; Agarwal R; Singh M; Khatri HL; Arora B
    Indian J Pathol Microbiol; 2001 Apr; 44(2):151-2. PubMed ID: 11883134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudomyxoma peritonei.
    Pan H; McGary C; LaVorgna KA; Nair S; Andrews J; Floch MH
    Gastroenterologist; 1998 Jun; 6(2):147-50. PubMed ID: 9660531
    [No Abstract]   [Full Text] [Related]  

  • 60. Mucin as a therapeutic target in pseudomyxoma peritonei.
    Choudry HA; O'Malley ME; Guo ZS; Zeh HJ; Bartlett DL
    J Surg Oncol; 2012 Dec; 106(7):911-7. PubMed ID: 22585683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.